59651-013 : Eptifibatide 20 mg/10ml Intravenous Injection


NDC59651-013
Labeler: Aurobindo Pharma Limited
Product Type: Human Prescription Drug
Drug Name:  Eptifibatide
Dosage Form: Intravenous Injection
Application #: ANDA206127
Rev. Date: 


NDC Package Codes:

  • 59651-013-10: 1 VIAL, SINGLE‑DOSE IN 1 CARTON (59651‑013‑10) > 10 ML IN 1 VIAL, SINGLE‑DOSE

Active Ingredients:

  • Eptifibatide

Dosage Strength:

  • 20 mg/10mL

Pharmaceutical Classes:

  • Decreased Platelet Aggregation [PE]
  • Platelet Aggregation Inhibitor [EPC]

Related Products:

Based on records with the same trade name.
  • 59651-012 Eptifibatide 75 mg/100ml Intravenous Injection by Aurobindo Pharma Limited
  • 59651-014 Eptifibatide 200 mg/100ml Intravenous Injection by Aurobindo Pharma Limited
  • 0338-9558 Eptifibatide 75 mg/100ml Intravenous Injection by Baxter Healthcare Corporation
  • 0338-9559 Eptifibatide 200 mg/100ml Intravenous Injection by Baxter Healthcare Corporation
  • 0703-1165 Eptifibatide 2 mg/ml Intravenous Injection, Solution by Teva Parenteral Medicines, Inc.
  • 0703-1179 Eptifibatide .75 mg/ml Intravenous Injection, Solution by Teva Parenteral Medicines, Inc.
  • 14335-070 Eptifibatide 2 mg/ml Intravenous Injection by Hainan Poly Pharm. Co., Ltd.
  • 14335-071 Eptifibatide .75 mg/ml Intravenous Injection by Hainan Poly Pharm. Co., Ltd.
  • 16729-259 Eptifibatide .75 mg/ml Intravenous Injection, Solution by Accord Healthcare Inc.
  • 16729-260 Eptifibatide 2 mg/ml Intravenous Injection, Solution by Accord Healthcare Inc.
  • 17478-902 Eptifibatide 2 mg/ml Intravenous Injection, Solution by Akorn, Inc.
  • 17478-903 Eptifibatide .75 mg/ml Intravenous Injection, Solution by Akorn, Inc.
  • 25021-408 Eptifibatide .75 mg/ml Intravenous Injection, Solution by Sagent Pharmaceuticals
  • 25021-409 Eptifibatide 2 mg/ml Intravenous Injection, Solution by Sagent Pharmaceuticals
  • 55150-218 Eptifibatide 75 mg/100ml Intravenous Injection by Auromedics Pharma LLC
  • 55150-219 Eptifibatide 20 mg/10ml Intravenous Injection by Auromedics Pharma LLC
  • 55150-220 Eptifibatide 200 mg/100ml Intravenous Injection by Auromedics Pharma LLC
  • 62147-0600 Eptifibatide 2 mg/ml Intravenous Injection, Solution by Usv Private Limited
  • 62147-0601 Eptifibatide .75 mg/ml Intravenous Injection, Solution by Usv Private Limited
  • 62147-0602 Eptifibatide 2 mg/ml Intravenous Injection, Solution by Usv Private Limited
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 59651-013 QR Code

< Prev: 59651-012Next: 59651-014 >




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 12 December 2015.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA